Neos Therapeutics Inc. announced the appointment of Richard I. Eisenstadt to the role of Chief Financial Officer, effective immediately. Mr. Eisenstadt has over twenty-five years of finance leadership experience in the healthcare, life sciences and emerging technology industries. Before joining Neos Therapeutics, he served as Chief Financial Officer of ArborGen Inc.
1st Jan change | Capi. | |
---|---|---|
+30.38% | 684B | |
+26.51% | 568B | |
-4.36% | 361B | |
+19.30% | 329B | |
+3.73% | 284B | |
+16.70% | 240B | |
+8.78% | 208B | |
-7.93% | 200B | |
+7.68% | 166B |